Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.50 |
| ▸ | BCL9 | O00512 | 1/20 | 0.49 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.49 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19942398 | 0.98 | KMT2A (0.57) | KMT2AMEN1GRIN2BALDH1A1RAB9A | |
| SCHEMBL2097232 | 0.87 | GRIN2B (0.54) | KMT2AMEN1GRIN2BALDH1A1RAB9A | |
| SCHEMBL542683 | 0.86 | MEN1 (0.58) | KMT2AMEN1GRIN2BALDH1A1RAB9A | |
| SCHEMBL4472527 | 0.86 | KMT2A (0.55) | KMT2AMEN1GRIN2BALDH1A1RAB9A | |
| SCHEMBL12551274 | 0.84 | MEN1 (0.54) | KMT2AMEN1GRIN2BALDH1A1RAB9A | |
| SCHEMBL31517046 | 0.83 | MEN1 (0.51) | KMT2AMEN1GRIN2BALDH1A1RAB9A | |
| SCHEMBL7384155 | 0.83 | MEN1 (0.51) | KMT2AMEN1GRIN2BALDH1A1RAB9A | |
| SCHEMBL5534524 | 0.83 | MEN1 (0.56) | KMT2AMEN1GRIN2BALDH1A1RAB9A | |
| SCHEMBL5534521 | 0.83 | MEN1 (0.56) | KMT2AMEN1GRIN2BALDH1A1RAB9A | |
| SCHEMBL17084538 | 0.83 | MEN1 (0.63) | KMT2AMEN1GRIN2BALDH1A1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6420418-B1 | INHIBITION AND PREVENTION OF LEUKOCYTE ADHESION; USED TO TREAT ADHESION-MEDIATED DISEASES SUCH AS ASTHMA, ALLERGIC RHINITIS, MULTIPLE SCLEROSIS; ATHEROSCLEROSIS, AND INFLAMMATORY BOWEL DISEASE | MERCK & CO., INC. | 2002-07-16 | — | — | US | disclosed |
| WO-2001012183-A1 | HETEROCYCLE AMIDES AS CELL ADHESION INHIBITORS | MERCK & CO., INC. (US) | 2001-02-22 | — | — | WO | disclosed |